Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

The effect of cell debris within biologic scaffolds upon the macrophage response.

Londono R, Dziki JL, Haljasmaa E, Turner NJ, Leifer CA, Badylak SF.

J Biomed Mater Res A. 2017 Aug;105(8):2109-2118. doi: 10.1002/jbm.a.36055. Epub 2017 Apr 12.

PMID:
28263432
2.

Safe Recombinant Outer Membrane Vesicles that Display M2e Elicit Heterologous Influenza Protection.

Watkins HC, Rappazzo CG, Higgins JS, Sun X, Brock N, Chau A, Misra A, Cannizzo JPB, King MR, Maines TR, Leifer CA, Whittaker GR, DeLisa MP, Putnam D.

Mol Ther. 2017 Apr 5;25(4):989-1002. doi: 10.1016/j.ymthe.2017.01.010. Epub 2017 Feb 16.

3.

Dendritic cells in host response to biologic scaffolds.

Leifer CA.

Semin Immunol. 2017 Feb;29:41-48. doi: 10.1016/j.smim.2017.01.001. Epub 2017 Feb 14. Review.

PMID:
28214177
4.

Molecular mechanisms of regulation of Toll-like receptor signaling.

Leifer CA, Medvedev AE.

J Leukoc Biol. 2016 Nov;100(5):927-941. Epub 2016 Jun 24. Review.

5.

Complex Negative Regulation of TLR9 by Multiple Proteolytic Cleavage Events.

Sinha SS, Cameron J, Brooks JC, Leifer CA.

J Immunol. 2016 Aug 15;197(4):1343-52. doi: 10.4049/jimmunol.1502357. Epub 2016 Jul 15.

6.

TLR9 stability and signaling are regulated by phosphorylation and cell stress.

Hasan M, Gruber E, Cameron J, Leifer CA.

J Leukoc Biol. 2016 Sep;100(3):525-33. doi: 10.1189/jlb.2A0815-337R. Epub 2016 Mar 8.

PMID:
26957214
7.

Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice.

Rappazzo CG, Watkins HC, Guarino CM, Chau A, Lopez JL, DeLisa MP, Leifer CA, Whittaker GR, Putnam D.

Vaccine. 2016 Mar 4;34(10):1252-8. doi: 10.1016/j.vaccine.2016.01.028. Epub 2016 Jan 29.

PMID:
26827663
8.

Electrostatically self-assembled biodegradable microparticles from pseudoproteins and polysaccharide: fabrication, characterization, and biological properties.

Potuck AN, Weed BL, Leifer CA, Chu CC.

Biomacromolecules. 2015 Feb 9;16(2):564-77. doi: 10.1021/bm5016255. Epub 2015 Jan 17.

PMID:
25531946
9.

Linking genetic variation in human Toll-like receptor 5 genes to the gut microbiome's potential to cause inflammation.

Leifer CA, McConkey C, Li S, Chassaing B, Gewirtz AT, Ley RE.

Immunol Lett. 2014 Dec;162(2 Pt A):3-9. doi: 10.1016/j.imlet.2014.07.017. Epub 2014 Oct 2. Review.

10.

Discordant results obtained with Francisella tularensis during in vitro and in vivo immunological studies are attributable to compromised bacterial structural integrity.

Singh A, Rahman T, Malik M, Hickey AJ, Leifer CA, Hazlett KR, Sellati TJ.

PLoS One. 2013;8(3):e58513. doi: 10.1371/journal.pone.0058513. Epub 2013 Mar 12.

11.

Participation of MyD88 and interleukin-33 as innate drivers of Th2 immunity to Trichinella spiralis.

Scalfone LK, Nel HJ, Gagliardo LF, Cameron JL, Al-Shokri S, Leifer CA, Fallon PG, Appleton JA.

Infect Immun. 2013 Apr;81(4):1354-63. doi: 10.1128/IAI.01307-12. Epub 2013 Feb 12.

12.

Traditional biochemical assays for studying toll-like receptor 9.

Leifer CA, Rose WA 2nd, Botelho F.

J Immunoassay Immunochem. 2013;34(1):1-15. doi: 10.1080/15321819.2012.666222. Review.

13.

Multifunctional role of dextran sulfate sodium for in vivo modeling of intestinal diseases.

Rose WA 2nd, Sakamoto K, Leifer CA.

BMC Immunol. 2012 Aug 1;13:41. doi: 10.1186/1471-2172-13-41.

14.

Heterozygous carriage of a dysfunctional Toll-like receptor 9 allele affects CpG oligonucleotide responses in B cells.

Knezević J, Pavlinić D, Rose WA 2nd, Leifer CA, Bendelja K, Gabrilovac J, Parcina M, Lauc G, Kubarenko AV, Petricevic B, Vrbanec D, Bulat-Kardum L, Bekeredjian-Ding I, Pavelić J, Dembić Z, Weber AN.

J Biol Chem. 2012 Jul 13;287(29):24544-53. doi: 10.1074/jbc.M111.337477. Epub 2012 May 21.

15.

Heat shock protein gp96 regulates Toll-like receptor 9 proteolytic processing and conformational stability.

Brooks JC, Sun W, Chiosis G, Leifer CA.

Biochem Biophys Res Commun. 2012 May 18;421(4):780-4. doi: 10.1016/j.bbrc.2012.04.083. Epub 2012 Apr 23.

16.

Negative regulation of signaling by a soluble form of toll-like receptor 9.

Chockalingam A, Cameron JL, Brooks JC, Leifer CA.

Eur J Immunol. 2011 Aug;41(8):2176-84. doi: 10.1002/eji.201041034. Epub 2011 Jul 4.

17.
18.

Early response of mucosal epithelial cells during Toxoplasma gondii infection.

Ju CH, Chockalingam A, Leifer CA.

J Immunol. 2009 Dec 1;183(11):7420-7. doi: 10.4049/jimmunol.0900640. Epub 2009 Nov 16.

19.

MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis.

Bowdish DM, Sakamoto K, Kim MJ, Kroos M, Mukhopadhyay S, Leifer CA, Tryggvason K, Gordon S, Russell DG.

PLoS Pathog. 2009 Jun;5(6):e1000474. doi: 10.1371/journal.ppat.1000474. Epub 2009 Jun 12.

20.

TLR9 traffics through the Golgi complex to localize to endolysosomes and respond to CpG DNA.

Chockalingam A, Brooks JC, Cameron JL, Blum LK, Leifer CA.

Immunol Cell Biol. 2009 Mar-Apr;87(3):209-17. doi: 10.1038/icb.2008.101. Epub 2008 Dec 16.

Supplemental Content

Loading ...
Support Center